LUCD - Lucid Diagnostics Inc. Stock Price and Quote

LUCD [NASD]

Index	-	P/E	-	EPS (ttm)	-1.55	Insider Own	80.40%	Shs Outstand	37.39M	Perf Week	0.00%
Market Cap	60.30M	Forward P/E	-	EPS next Y	-0.98	Insider Trans	0.00%	Shs Float	5.67M	Perf Month	1.45%
Income	-56.20M	PEG	-	EPS next Q	-0.34	Inst Own	5.90%	Short Float / Ratio	2.35% / 1.32	Perf Quarter	0.72%
Sales	0.40M	P/S	150.74	EPS this Y	-93.10%	Inst Trans	-5.68%	Short Interest	0.13M	Perf Half Y	-12.50%
Book/sh	0.62	P/B	2.26	EPS next Y	24.00%	ROA	-126.00%	Target Price	5.22	Perf Year	-57.45%
Cash/sh	0.52	P/C	2.68	EPS next 5Y	-	ROE	-168.50%	52W Range	1.11 - 3.64	Perf YTD	2.94%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-200.60%	52W High	-61.54%	Beta	-
Dividend %	-	Quick Ratio	2.90	Sales past 5Y	-	Gross Margin	-	52W Low	26.70%	ATR	0.13
Employees	74	Current Ratio	2.90	Sales Q/Q	-66.70%	Oper. Margin	-	RSI (14)	44.31	Volatility	8.64% 9.80%
Optionable	No	Debt/Eq	0.22	EPS Q/Q	-1.30%	Profit Margin	-	Rel Volume	6.86	Prev Close	1.39
Shortable	Yes	LT Debt/Eq	0.00	Earnings	-	Payout	-	Avg Volume	101.31K	Price	1.40
Recom	1.60	SMA20	-9.24%	SMA50	0.47%	SMA200	-26.47%	Volume	695,430	Change	0.72%

Dec-27-21

Initiated

Ascendiant Capital Markets

Buy

$16

Nov-08-21

Initiated

Needham

Buy

$17

Nov-08-21

Initiated

Cantor Fitzgerald

Overweight

$21

Nov-08-21

Initiated

BTIG Research

Buy

$14

Mar-31-23 12:45PM	Lucid Diagnostics Provides Update on Newly Published Future Effective Medicare Local Coverage Determination on Molecular Testing for Detection of Esophageal Precancer and Cancer PR Newswire
Mar-20-23 09:03PM	PAVmed Inc. (NASDAQ:PAVM) Q4 2022 Earnings Call Transcript Insider Monkey
Mar-17-23 04:15AM	Lucid Diagnostics Inc. (NASDAQ:LUCD) Q4 2022 Earnings Call Transcript Insider Monkey
Mar-16-23 01:22AM	Q4 2022 PAVmed Inc Earnings Call Thomson Reuters StreetEvents
Mar-15-23 02:43AM	Q4 2022 Lucid Diagnostics Inc Earnings Call Thomson Reuters StreetEvents
07:09PM	Loading…
Mar-14-23 07:09PM	PAVmed Provides Business Update and Preliminary Fourth Quarter and Full Year 2022 Financial Results PR Newswire +6.83%
01:28PM	/C O R R E C T I O N -- Lucid Diagnostics/ PR Newswire
Mar-03-23 08:15AM	PAVmed to Hold a Business Update Conference Call and Webcast on March 15, 2023 PR Newswire
08:15AM	Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on March 14, 2023 PR Newswire
Feb-28-23 08:30AM	PAVmed Digital Health Subsidiary Veris Health's Veris Cancer Care Platform Goes Live PR Newswire
Feb-15-23 08:30AM	Lucid Diagnostics Holds First #CheckYourFoodTube Precancer Testing Event PR Newswire
Jan-18-23 06:24AM	PAVmed, Lucid Diagnostics Pause Some Development Programs, Announce Layoffs Benzinga -13.46%
Jan-17-23 04:05PM	PAVmed and Lucid Diagnostics Provide Strategic Business Update Business Wire +20.00%
Jan-11-23 08:00AM	PAVmed and Lucid Diagnostics to Provide Strategic Business Update Business Wire
Dec-22-22 08:25AM	PAVmed Partners with Novosound on Ultrasound Imaging Technology Business Wire
08:25AM	Loading…
Dec-15-22 08:25AM	PAVmed Digital Health Subsidiary Veris Health Launches Veris Cancer Care Platform Business Wire
Dec-12-22 08:43AM	Here's Why Lucid Diagnostics (NASDAQ:LUCD) Must Use Its Cash Wisely Simply Wall St. -5.82%
Dec-08-22 08:25AM	Lucid Diagnostics Selected as Finalist for Medtech Company of the Year 2022 by Medical Device + Diagnostic Industry Business Wire +5.52%
Dec-01-22 08:25AM	Lucid Diagnostics Presents Real-World EsoCheck Data at the American Association for Cancer Research Business Wire
Nov-15-22 04:20PM	PAVmed Provides Business Update and Third Quarter 2022 Financial Results Business Wire -11.89%
Nov-14-22 04:40PM	Lucid Diagnostics Provides Business Update and Third Quarter 2022 Financial Results Business Wire
Nov-10-22 08:25AM	Lucid Diagnostics to Participate in Canaccord Genuitys MedTech, Diagnostics and Digital Health & Services Forum Business Wire
Nov-09-22 08:25AM	Lucid Diagnostics Commences Production of EsoCheck Devices with High-Volume Manufacturer Business Wire +15.14%
Nov-02-22 08:25AM	Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 14, 2022 Business Wire
Aug-15-22 04:25PM	Lucid Diagnostics Provides Business Update and Preliminary Second Quarter 2022 Financial Results Business Wire
09:31AM	What Type Of Shareholders Make Up Lucid Diagnostics Inc.'s (NASDAQ:LUCD) Share Registry? Simply Wall St.
Aug-11-22 08:25AM	Lucid Diagnostics Launches Stage II Lucid Test Center Expansion in California, Texas, Florida, and Ohio Business Wire
Aug-04-22 08:25AM	Newly Published American Gastroenterological Association Clinical Practice Update Supports Esophageal Precancer Screening Using Lucid Diagnostics EsoGuard® and EsoCheck® Technologies Business Wire +5.67%
Aug-02-22 08:25AM	Lucid Diagnostics Laboratory Executes Four New Participating Provider Agreements Business Wire
Aug-01-22 08:25AM	Lucid Diagnostics to Hold a Business Update Conference Call on August 15, 2022 Business Wire
08:25AM	Loading…
Jul-18-22 08:25AM	Lucid Diagnostics to Participate in the Canaccord 42nd Annual Growth Conference and the 7th Annual Needham Med Tech & Diagnostics 1x1 Conference Business Wire
Jul-04-22 01:57PM	Is Lucid Diagnostics (NASDAQ:LUCD) In A Good Position To Deliver On Growth Plans? Simply Wall St.
May-13-22 08:25AM	PAVmed and Lucid Diagnostics Chairman & CEO Lishan Aklog, M.D. Named Top 50 Healthcare Technology CEO Business Wire
May-11-22 04:00PM	Lucid Diagnostics Provides Business Update and Preliminary First Quarter 2022 Financial Results Business Wire -7.46%
May-09-22 08:25AM	Lucid Diagnostics Laboratory Executes Participating Provider Agreement with MediNcrease Health Plans Business Wire -6.70%
Apr-25-22 08:25AM	Lucid Diagnostics to Hold a Business Update Conference Call on May 11, 2022 Business Wire
Apr-14-22 12:02PM	2 Strong Buy Penny Stocks That Offer Massive Potential Gains TipRanks
Apr-04-22 08:25AM	Lucid Diagnostics Provides Updates on Newly Published Esophageal Precancer Clinical Guideline and Proposed Medicare Local Coverage Determination Business Wire
Mar-30-22 08:25AM	Lucid Diagnostics to Participate in the Needham 21st Annual Healthcare Conference Business Wire
Mar-29-22 04:11PM	PAVmed Provides Business Update and Preliminary Fourth Quarter and Full Year 2021 Financial Results Business Wire +6.56%
11:35AM	Lucid Diagnostics to Have a Productive Year, Says Cantor Fitzgerald Investing.com
Mar-28-22 04:47PM	Lucid Diagnostics Provides Business Update and Preliminary Fourth Quarter and Full Year 2021 Financial Results Business Wire
Mar-24-22 08:25AM	PAVmed Subsidiary Lucid Diagnostics Announces Launch of VA EsoGuard® Study Business Wire +5.94%
Mar-23-22 08:25AM	PAVmed Subsidiary Lucid Diagnostics Launches Next Phase of Lucid Test Centers Business Wire
Mar-08-22 08:30AM	PAVmed to Hold a Business Update Conference Call on March 29, 2022 Business Wire
Mar-07-22 08:30AM	Lucid Diagnostics to Hold a Business Update Conference Call on March 28, 2022 Business Wire
Mar-04-22 08:25AM	Lucid Diagnostics to Participate in the LSI USA 22 Emerging Medtech Summit Business Wire
Mar-03-22 08:25AM	PAVmed Subsidiary Lucid Diagnostics Launches LucidDx Labs to Accommodate EsoGuard Testing Growth Business Wire
Feb-24-22 08:25AM	PAVmed Appoints Shaun ONeil as Chief Operating Officer Business Wire +5.97%
Feb-15-22 08:25AM	Evernorth Executive and Healthcare Services Industry Leader Joan Harvey Named to PAVmed Board of Directors Business Wire +6.85%
Feb-10-22 08:25AM	Lucid Diagnostics to Participate in a Fireside Chat at the BTIG MedTech Digital Health, Life Science, and Diagnostics Tools Conference Business Wire
Jan-19-22 07:26AM	Todays Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday InvestorPlace
Jan-12-22 08:25AM	PAVmed and Lucid Diagnostics Welcome New Full-Time Investor Relations Team Business Wire
Jan-06-22 08:30AM	Lucid Diagnostics to Participate in a Fireside Chat at the 24th Annual Needham Virtual Growth Conference Business Wire
Dec-01-21 08:30AM	PAVmed Subsidiary Lucid Diagnostics Launches EsoGuard Telemedicine Program in Partnership with UpScriptHealth Business Wire
Nov-17-21 08:30AM	Lucid Diagnostics to Present at Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum Business Wire -12.14%
Nov-16-21 04:13PM	PAVmed and Lucid Provide Business Update and Preliminary Third Quarter 2021 Financial Results Business Wire
Nov-11-21 08:30AM	PAVmed Subsidiary Lucid Diagnostics Launches Next Phase of Lucid Test Centers Business Wire
Nov-03-21 08:30AM	PAVmed and Lucid to Hold Joint Business Update Conference Call on November 16, 2021 Business Wire
Oct-28-21 08:30AM	Lucid Diagnostics EsoGuard Esophageal DNA Test Wins "Diagnostics Innovation of the Year" Award Business Wire +8.16%
Oct-21-21 12:59PM	ADDING MULTIMEDIA Lucid Diagnostics Appoints Suman Verma MD, PhD as Chief Scientific Officer Business Wire +12.80%
07:56AM	3 Stocks Insiders Are Buying Benzinga
Oct-18-21 06:09PM	Lucid Diagnostics Announces Closing of Nasdaq Initial Public Offering Business Wire
Oct-14-21 12:12PM	Lucid Diagnostics stock opens about 9% below the IPO price, and keeps falling MarketWatch
Oct-13-21 10:15PM	Lucid Diagnostics Announces Pricing of Initial Public Offering GlobeNewswire

Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma (EAC). It offers EsoCheck, a cell collection device to prevent EAC deaths; and EsoGuard, an Esophageal DNA Test. The company was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. is a subsidiary of PAVmed Inc.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Lapidus Stanley	Director	Sep 20	Sale	1.70	33,864	57,683	135,456	Sep 22 11:46 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Upgrade your FINVIZ experience